TUBB2B and breast cancer: TUBB2B overexpression is a predictor of poor OS in PAM50-basal breast cancer patients (Fig. 1D (GSE65194), 1E (GSE58812)), although analysis with TNBC patients in the TCGA datasets does not show significance (Fig. 1F).